Molecular neurobiology of acute liver failure

Seminars in Liver Disease

Volumn 23, Issue 3, 2003, Pages 251-258

  Butterworth, Roger F ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Acute liver failure; Ammonia; Astrocytes; Brain edema; Brain energy metabolism; Gene expression; Hypothermia; Osmoregulation; Transporters

Indexed keywords

AMINO ACID TRANSPORTER; AMMONIA; AQUAPORIN 4; BENZODIAZEPINE RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUCOSE TRANSPORTER 1; LACTIC ACID; STRUCTURAL PROTEIN;

ASTROCYTE; BRAIN EDEMA; CELL SWELLING; DISEASE SEVERITY; ENERGY METABOLISM; GENE EXPRESSION; HEPATIC ENCEPHALOPATHY; HUMAN; HUMAN TISSUE; HYPOTHERMIA; LIVER FAILURE; NEUROBIOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OSMOREGULATION; PRIORITY JOURNAL; REVIEW;

ASTROCYTES; BRAIN; BRAIN EDEMA; HUMANS; LIVER FAILURE, ACUTE;

EID: 0043009731     PISSN: 02728087     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42643     Document Type: Review

References (59)

1. Kato M, Hughes RD, Keays RT, Williams R. Electron microscopic study of brain capillaries in cerebral edema from fulminant hepatic failure. Hepatology 1992;15:1060-1066
2. Traber PG, DalCanto M, Ganger DR, Blei AT. Electron microscopic evaluation of brain edema in rabbits with galactosamine-induced fulminant hepatic failure: ultrastructure and integrity of the blood-brain barrier. Hepatology 1987;7:1273-1277
3. Potvin M, Morrison HF, Hinchey EJ, et al. Cerebral abnormalities in hepatectomized rats with acute hepatic coma. Lab Invest 1984;50:560-564
4. Desjardins P, Michalak A, Therrien G, et al. Increased expression of the astrocytic/endothelial cell glucose transporter (and water channel) protein GLUT-1 in relation to brain glucose metabolism and edema in acute liver failure. Hepatology 2001;34:237 (Abst 254)
5. Desjardins P, Bélanger M, Butterworth RF. Alterations in expression of genes coding for key astrocytic proteins in acute liver failure. J Neurosci Res 2001;66:967-971
6. Holmin T, Agardh CD, Alinder G, et al. The influence of total hepatectomy on cerebral energy state, ammonia-related amino acids of the brain and plasma amino acids in the rat. Eur J Clin Invest 1983;13:215-220
7. Swain M, Butterworth RF, Blei AT. Ammonia and related amino acids in the pathogenesis of brain edema in acute ischemic liver failure in rats. Hepatology 1992;15:449-453
8. Mans AM, DeJoseph MR, Hawkins RA. Metabolic abnormalities and grade of encephalopathy in acute hepatic failure. J Neurochem 1994;63:1829-1838
9. Swain MS, Bergeron M, Audet R, et al. Monitoring of neurotransmitter amino acids by means of an indwelling cisterna magna catheter: a comparison of two rodent models of fulminant liver failure. Hepatology 1992;16:1028-1035
10. Peeling J, Shoemaker L, Gauthier T, et al. Cerebral metabolic and histological effects of thioacetamide-induced liver failure. Am J Physiol 1993;265:G572-G578
11. Clemmesen JO, Larsen FS, Kondrup J, et al. Cerebral herniation in patients with acute liver failure is correlated with arterial ammonia concentration. Hepatology 1999;29:648-653
12. Cooper AJ, Plum F. Biochemistry and physiology of brain ammonia. Physiol Rev 1987;67:440-519
13. Butterworth RF. Pathophysiology of hepatic encephalopathy: a new look at ammonia. Metab Brain Dis 2002;17:221-227
14. Dejong CHC, Kampman MT, Deutz NEP, Soeters PB. Cerebral cortex ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat. J Neurochem 1992;59:1071-1079
15. Jalan R, Dalmink SWM, Lee O, et al. Moderate hypothermia for uncontrolled intracranial hypertension in acute liver failure. Lancet 1999;354:1164-1168
16. Record CO, Buxton B, Chase RA, et al. Plasma and brain amino acids in fulminant hepatic failure and their relationship to hepatic encephalopathy. Eur J Clin Invest 1976;6:387-394
17. McConnell JR, Antonson DL, Ong CS, et al. Proton spectroscopy of brain glutamine in acute liver failure. Hepatology 1995;22:69-74
18. Gupta RK, Saraswat VA, Poptani H, et al. Magnetic resonance imaging and localized in vivo proton spectroscopy in patients with fulminant hepatic failure. Am J Gastroenterol 1993;88:670-674
19. 13C] NMR study. Hepatology 2003;37:420-428
20. Tyce GM, Ogg J, Owen CA Jr. Metabolism of acetate to amino acids in brains of rats after complete hepatectomy. J Neurochem 1981;36:640-650
21. Zimmermann C, Ferenci P, Pifl C, et al. Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission. Hepatology 1989;9:594-601
22. Hertz L, Murthy CR, Lai JC, Fitzpatrick SM, Cooper AJ. Some metabolic effects of ammonia on astrocytes and neurons in primary cultures. Neurochem Pathol 1987;6:97-129
23. Bosman DK, Deutz NEP, Maas MAW, et al. Amino acid release from cerebral cortex in experimental acute liver failure, studied by in vivo cerebral cortex microdialysis. J Neurochem 1992;59:591-599
24. Deutz NEP, DeGraaf AA, De Haan JG, et al. In vivo brain 1H-NMR spectroscopy (IH-NMRS) during acute hepatic encephalopathy (HE). In: Soeters PB, Wilson JHP, Meijer AJ, Holm E, eds. Advances in Ammonia Metabolism and Hepatic Encephalopathy. Amsterdam: Excerpta Medica; 1988:439-446
25. Chatauret N, Rose C, Therrien G, Butterworth RF. Mild hypothermia prevents cerebral edema and CSF lactate accumulation in acute liver failure. Metab Brain Dis 2001;16:95-102
26. Tofteng F, Jorgensen L, Hansen BA, et al. Cerebral microdialysis in patients with fulminant hepatic failure. Hepatology 2002;36:1333-1340
27. Nyberg SL, Cerra FB, Gruetter R. Brain lactate by magnetic resonance spectroscopy during fulminant hepatic failure in the dog. Liver Transpl Surg 1998;4:158-165
28. Staub F, Baethmann A, Peters J, et al. Effects of lactacidosis on glial cell volume and viability. J Cereb Blood Flow Metab 1990;10:866-876
29. Lai JCK, Cooper AJL. α-ketoglutarate dehydrogenase complex: kinetic properties, regional distribution and effects of inhibitors. J Neurochem 1986;47:1376-1386
30. Lowry OH, Passonneau JV. Kinetic evidence for multiple binding sites on phosphofructokinase. J Biol Chem 1966;241:2268-2279
31. Eng LF, Ghirnikar RS, Lee YL. Glial fibrillary acidic protein: GFAP-31 years (1969-2000). Neurochem Res 2000;25:1439-1451
32. Bélanger M, Desjardins P, Chatauret N, Butterworth RF. Loss of expression of glial fibrillary acidic protein in acute hyperammonemia. Neurochem Int 2002;41:155-160
33. Norenberg MD, Neary JT, Norenberg LO, McCarthy M. Ammonia induced decreased in glial fibrillary acidic protein in cultured astrocytes. J Neuropathol Exp Neurol 1990;49:399-405
34. Ding M, Eliasson C, Betsholtz C, et al. Altered taurine release following hypotonic stress in astrocytes from mice deficient for GFAP and vimentin. Mol Brain Res 1998;62:77-81
35. Tanaka K, Watase K, Manabe T, et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science 1997;276:1699-1702
36. Michalak A, Rose C, Butterworth J, Butterworth RF. Neuroactive amino acids and glutamate (NMDA) receptors in frontal cortex of rats with experimental acute liver failure. Hepatology 1996;24:908-913
37. Ellis AJ, Wendon JA, Williams R. Subclinical seizure activity and prophylactic phenytoin infusion in acute liver failure: a controlled clinical trial. Hepatology 2000;32:536-541
38. Knecht K, Michalak A, Rose C, et al. Decreased glutamate transporter (GLT-1) expression in frontal cortex of rats with acute liver failure. Neurosci Lett 1997;229:201-203
39. Butterworth RF. Glutamate transporters in hyperammonemia. Neurochem Int 2002;41:81-85
40. Van Harreveld A, Fifkova E. Light- and electron-microscopic changes in central nervous tissue after electrophoretic injection of glutamate. Exp Mol Pathol 1971;15:61-81
41. Zafra F, Aragon C, Olivares L, et al. Glycine transporters are differentially expressed among CNS cells. J Neurosci 1995;15:3952-3969
42. Zwingmann C, Desjardins P, Hazell A, et al. Reduced expression of astrocytic glycine transporter (GLYT-1) in acute liver failure. Metab Brain Dis 2002;17:263-273
43. Michalak A, Chatauret N, Butterworth RF. Evidence for a serotonin transporter deficit in experimental acute liver failure. Neurochem Int 2001;38:163-168
44. Michalak A, Rose C, Butterworth RF. Loss of noradrenaline transporter sites in frontal cortex of rats with acute (ischemic) liver failure. Neurochem Int 2001;38:25-30
45. Fischbarq J, Kuang KY, Vera JC, et al. Glucose transporters serve as water channels. Proc Natl Acad Sci USA 1990;87:3244-3247
46. Margulies JE, Thompson RC, Demetriou AA. Aquaporin-4 water channel is up-regulated in the brain in fulminant hepatic failure. Hepatology 1999;30:395A (Abst)
47. Itzhak Y, Roig-Cantisano A, Dombro RS, et al. Acute liver failure and hyperammonemia increase peripheral-type receptor binding and pregnenolone synthesis in mouse brain. Brain Res 1995;705:345-348
48. Takahashi H, Koehler RC, Brusilow SW, Traystman RJ. Inhibition of brain glutamine accumulation prevents cerebral edema in hyperammonemic rats. Am J Physiol 1991;261:H825-H829
49. Blei AT, Olafsson S, Therrien G, Butterworth RF. Ammonia-induced brain edema and intracranial hypertension in rats after portacaval anastomosis. Hepatology 1994;19:1437-1444
50. Rose C, Michalak A, Rama Rao KV, et al. L-ornithine L-aspartate lowers plasma and cerebrospinal fluid ammonia and prevents brain edema in rats with acute liver failure. Hepatology 1999;30:636-640
51. Rose C, Michalak A, Pannunzio M, et al. Mild hypothermia delays the onset of coma and prevents brain edema and extracellular brain glutamate accumulation in rats with acute liver failure. Hepatology 2000;3:872-877
52. Traber P, DalCanto M, Ganger D, Blei AT. Effect of body temperature on brain edema and encephalopathy in the rat after hepatic devascularization. Gastroenterology 1989;96:885-891
53. Schenker S, Warren KS. Effect of temperature variation on toxicity and metabolism of ammonia in mice. J Lab Clin Med 1962;60:291-301
54. Basile AS, Hughes RD, Harrison PM, et al. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med 1991;325:473-478
55. Basile AS, Pannell L, Jaouni T, et al. Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy. Proc Natl Acad Sci USA 1990;87:5263-5267
56. Widler P, Fisch HU, Schoch P, et al. Increased benzodiazepine-like activity is neither necessary nor sufficient to explain acute hepatic encephalopthy in the thioacetamide-treated rat. Hepatology 1993;18:1459-1464
57. Ferenci P, Grimm G.Treatment of hepatic encephalopathy with the benzodiazepine antagonist flumazenil. In: Butterworth RF, Pomier Layrargues G, eds. Hepatic Encephalopathy: Pathophysiology and Treatment. Clifton, NJ; 1989:597-612
58. Van der Rijt CC, de Knegt RJ, Schalm SW, et al. Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit. Metab Brain Dis 1990;5:131-141
59. Vogels BA, Maas MA, Daalhuisen J, et al. Memantine, a noncompetitive NMDA receptor antagonist improves hyperammonemia-induced encephalopathy and acute hepatic encephalopathy in rats. Hepatology 1997;25:820-827